CRISPR Therapeutics AG (CRSP)
56.71
+0.25
(+0.44%)
USD |
NASDAQ |
Dec 24, 16:00
CRISPR Therapeutics Market Cap: 5.404B for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 117.47B |
| Intellia Therapeutics, Inc. | 1.111B |
| Novartis AG | 266.48B |
| Beam Therapeutics, Inc. | 2.856B |
| BeOne Medicines Ltd. | 34.50B |
Market Cap Related Metrics
| PS Ratio | 129.35 |
| PEG Ratio | -0.1041 |
| Price to Book Value | 2.821 |
| Price | 56.71 |
| Earnings Yield | -9.84% |
| PEGY Ratio | -0.1041 |